PharOS Polska was founded in 2008, through a joint venture of PharOS Ltd. and the Swiss-based company Nortrade Pharma. Through its local presence, the company will increase its focus and market presence in the rapidly emerging Central and Eastern Europe.

PharOS Polska, headquartered in Warsaw, offers the following range of products and services:

• Generic Development
• Registration including preparation and submission of eCTD
• Licensing services.